Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model

International Journal of Molecular Sciences(2024)10.3390/ijms25105392Source: DataRank Database

Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model is a research paper published in International Journal of Molecular Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (26)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Maria M. Parrilla,Sarah G. Samaranayake ORCID,Dormarie E. Rivera-Rodriguez ORCID,Sung Bo Yoon ORCID,Ramireddy Bommireddy ORCID

Live enrichment

PubMed:19767382

NIH/NIAID

Grant: T32AI106699

NIH/NIAID

Grant: R44CA257278-01A1S1

National Institutes of Health

Grant: 5T32AI106699-09

Antimicrobial Resistance and Therapeutic Discovery Training Program

National Institutes of Health

Grant: 1R44CA257278-01A1

Clinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer

goldLicense: cc-by

publisherhttps://www.mdpi.com/1422-0067/25/10/5392/pdf?version=1715762524

publisherhttps://www.mdpi.com/1422-0067/25/10/5392/pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11121204/pdf/ijms-25-05392.pdf

https://doi.org/10.3390/ijms25105392

https://doi.org/10.20944/preprints202404.0261.v1

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

Lung NeoplasmsMedicine and PharmacologyTriple Negative Breast NeoplasmsArticleCD4+ T cellmyeloid-derived suppressor cellMiceGene Knockout TechniquesLymphocytes, Tumor-InfiltratingOncology and OncogenicsCell Line, TumorTumor MicroenvironmentAnimalsHumansEnhancer of Zeste Homolog 2 ProteinCell ProliferationMice, Inbred BALB Ctumor-infiltrating neutrophilsinvasionGene Expression Regulation, NeoplasticDisease Models, Animaltriple-negative breast cancerFemaleCD8+ T cell

Sustainable Development Goals

SDG 3: 3. Good health